(BMY) stock gains after the company reported better-than-expected Q1 2026 financials and reaffirmed its full-year outlook. Read more here.
Bristol Myers Squibb reported a first-quarter profit that beat Wall Street expectations on Thursday, helped by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results